FLT4 and lung carcinoma: In the present study, immunohistochemical analysis of 52 lung cancer patients demonstrated that VEGFR-3 is expressed not only in lymphatic endothelial cells, but also in microvascular endothelial cells and the tumor cell cytoplasm, which is in accordance with the studies by Li et al and Peng et al (12,13).